Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 9 | 2013 | 1762 | 0.740 |
Why?
|
| Polymorphism, Single Nucleotide | 16 | 2015 | 2484 | 0.660 |
Why?
|
| Genotype | 10 | 2015 | 1866 | 0.610 |
Why?
|
| Genetics, Population | 6 | 2015 | 439 | 0.380 |
Why?
|
| Haplotypes | 6 | 2015 | 647 | 0.360 |
Why?
|
| Biostatistics | 1 | 2010 | 21 | 0.320 |
Why?
|
| Genome, Human | 6 | 2015 | 823 | 0.320 |
Why?
|
| Algorithms | 3 | 2012 | 1953 | 0.310 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2008 | 101 | 0.270 |
Why?
|
| Models, Genetic | 6 | 2015 | 970 | 0.230 |
Why?
|
| Gene Frequency | 4 | 2015 | 700 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2012 | 2465 | 0.130 |
Why?
|
| Genetic Variation | 4 | 2015 | 1415 | 0.110 |
Why?
|
| Software | 2 | 2009 | 670 | 0.110 |
Why?
|
| Schizophrenia | 2 | 2008 | 529 | 0.110 |
Why?
|
| Amidinotransferases | 1 | 2013 | 5 | 0.100 |
Why?
|
| Linkage Disequilibrium | 4 | 2009 | 478 | 0.100 |
Why?
|
| Alleles | 3 | 2015 | 1139 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 893 | 0.100 |
Why?
|
| INDEL Mutation | 1 | 2013 | 33 | 0.100 |
Why?
|
| Muscular Diseases | 1 | 2013 | 67 | 0.100 |
Why?
|
| Simvastatin | 1 | 2013 | 106 | 0.100 |
Why?
|
| Computational Biology | 2 | 2015 | 578 | 0.090 |
Why?
|
| Human Genome Project | 1 | 2012 | 22 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2015 | 585 | 0.090 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2011 | 16 | 0.090 |
Why?
|
| Selection, Genetic | 1 | 2015 | 538 | 0.090 |
Why?
|
| Databases, Genetic | 1 | 2012 | 282 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2011 | 62 | 0.080 |
Why?
|
| Evolution, Molecular | 2 | 2015 | 878 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 192 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 394 | 0.080 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 630 | 0.080 |
Why?
|
| Hemoglobin, Sickle | 1 | 2009 | 17 | 0.070 |
Why?
|
| Malaria | 1 | 2009 | 26 | 0.070 |
Why?
|
| Humans | 16 | 2015 | 93515 | 0.070 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2008 | 11 | 0.070 |
Why?
|
| Case-Control Studies | 5 | 2012 | 1931 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 109 | 0.070 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2007 | 17 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2012 | 565 | 0.070 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2007 | 30 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 306 | 0.060 |
Why?
|
| Chromosome Mapping | 4 | 2012 | 1052 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 691 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2007 | 189 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2007 | 261 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1985 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 1053 | 0.050 |
Why?
|
| Genomics | 1 | 2007 | 848 | 0.040 |
Why?
|
| Italy | 1 | 2015 | 110 | 0.030 |
Why?
|
| United Kingdom | 1 | 2015 | 190 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2015 | 402 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2013 | 3 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 3110 | 0.030 |
Why?
|
| Fathers | 1 | 2013 | 44 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 254 | 0.020 |
Why?
|
| Mutation Rate | 1 | 2013 | 54 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2013 | 103 | 0.020 |
Why?
|
| Mothers | 1 | 2013 | 142 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 22 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2012 | 38 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 7061 | 0.020 |
Why?
|
| Cholesterol | 1 | 2013 | 364 | 0.020 |
Why?
|
| Reference Standards | 1 | 2012 | 146 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2013 | 454 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 1118 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2012 | 260 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2011 | 125 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2012 | 613 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 450 | 0.020 |
Why?
|
| Aged | 3 | 2015 | 20434 | 0.020 |
Why?
|
| Young Adult | 2 | 2015 | 6930 | 0.020 |
Why?
|
| Gambia | 1 | 2009 | 2 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 537 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 2464 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 1117 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2008 | 47 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2008 | 83 | 0.020 |
Why?
|
| Middle Aged | 3 | 2015 | 27573 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 608 | 0.020 |
Why?
|
| Aminopeptidases | 1 | 2007 | 14 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2007 | 40 | 0.020 |
Why?
|
| Receptors, Interleukin | 1 | 2007 | 38 | 0.020 |
Why?
|
| North America | 1 | 2007 | 195 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2007 | 140 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 589 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2007 | 469 | 0.020 |
Why?
|
| Bipolar Disorder | 1 | 2008 | 399 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 826 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 894 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2012 | 808 | 0.010 |
Why?
|
| Male | 3 | 2013 | 44557 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1229 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1917 | 0.010 |
Why?
|
| Adult | 2 | 2015 | 27918 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 9606 | 0.010 |
Why?
|
| Child | 1 | 2013 | 7355 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 3830 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 3502 | 0.010 |
Why?
|
| Female | 2 | 2013 | 48702 | 0.010 |
Why?
|